Reduced-intensity conditioning allogeneic stem cell transplantation in malignant lymphoma: current status

por Zhang, Le, Zhang, Yi-Zhuo
Publicado 2013

Histone Deacetylase Inhibition: An Important Mechanism in the Treatment of Lymphoma

por Guo, Shan-qi, Zhang, Yi-zhuo
Publicado 2012

Fludarabine-based versus CHOP-like regimens with or without rituximab in patients with previously untreated indolent lymphoma: a retrospective analysis of safety and efficacy

por Xu, Xiao-xiao, Yan, Bei, Wang, Zhen-xing, Yu, Yong, Wu, Xiao-xiong, Zhang, Yi-zhuo
Publicado 2013

Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China

por Zhong, Yu-Ping, Zhang, Yi-Zhuo, Liao, Ai-Jun, Li, Su-Xia, Tian, Chen, Lu, Jin
Publicado 2017

Prognostic factors associated with solitary plasmacytoma

por Guo, Shan-qi, Zhang, Le, Wang, Ya-fei, Sun, Bao-cun, Zhang, Lian-yu, Zhang, Jin, Wang, Guowen, Zhang, Yi-zhuo
Publicado 2013

Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth

por Qu, Fu-Lian, Xia, Bing, Li, Su-Xia, Tian, Chen, Yang, Hong-Liang, Li, Qian, Wang, Ya-Fei, Yu, Yong, Zhang, Yi-Zhuo
Publicado 2015

Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the Kidney

por Hong, Ye, Que, Yi, Hu, Yang, Shi, Bo-yun, Zhu, Jia, Wang, Juan, Huang, Jun-ting, Sun, Fei-fei, Zhang, Lian, Zhou, Xin-ke, Lu, Su-ying, Zhang, Yi-zhuo
Publicado 2022

Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma

por Que, Yi, Zhang, Xiao-Long, Liu, Ze-Xian, Zhao, Jing-Jing, Pan, Qiu-Zhong, Wen, Xi-Zhi, Xiao, Wei, Xu, Bu-Shu, Hong, Dong-Chun, Guo, Tian-Hui, Shen, Lu-Jun, Fan, Wei-Jun, Chen, Huo-Ying, Weng, De-Sheng, Xu, Hai-Rong, Zhou, Peng-Hui, Zhang, Yi-Zhuo, Niu, Xiao-Hui, Zhang, Xing
Publicado 2021